Core Viewpoint - The company, Wihua New Materials, is acquiring a 70% stake in Jiangsu Heyutai Chemical from Zhejiang Xinhhe Biological for a cash consideration of 154 million yuan, aiming to enhance operational efficiency and profitability in the long term [1] Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans [1] - After the transaction, Heyutai will become a controlled subsidiary of Wihua New Materials [1] Group 2: Financial Performance of Target Company - Heyutai is currently in a loss-making phase due to low market prices for agricultural chemical products and insufficient capacity utilization [1] - However, there are signs of improvement, with losses in the first half of 2025 narrowing compared to the same period last year, and further operational improvements expected in the third quarter [1] Group 3: Future Strategy - The company plans to expand sales channels, improve capacity utilization, optimize product processes, and strengthen internal management to achieve profitability for Heyutai by 2026 [1] - The acquisition will provide stable supply support for three key raw materials used by Heyutai, which are also major products of the listed company and its subsidiaries, reducing uncertainty in external procurement [1]
巍华新材子公司拟1.54亿元收购禾裕泰70%股权